Background: Heart failure, or congestive heart failure (CHF) is a very common disease, affecting approximately 4.8 million Americans. In recent years, many other types of heart disease have been decreasing, and the incidence of CHF has been increasing. This may be because other patients with heart disease have a longer survival period, but their heart is still damaged, which leads to the occurrence of CHF. At the same time, due to the increase in the elderly population, there are more and more high-risk groups suffering from CHF. There are approximately 400,000 new cases of CHF in the United States each year. This disease is also the most common diagnosis in hospitals for patients over 65 years of age. Accurate and reliable diagnostic criteria for congestive heart failure (CHF) is the actual pressure inside the heart. Unfortunately, this technique for measuring cardiac pressure has not been applied clinically. The monitoring of heart rate, blood pressure, body weight and other indicators currently used clinically has not been shown to improve the clinical outcome of CHF patients or to reduce the damage of CHF to patients because these measurements lack sufficient predictive power. Founded in 2007, Endotronix has five patented technologies, including the development of advanced biosensors, mobile medical technology and clinical services, and the application of new digital heart failure management models. It provides a heartbeat patient biosensor heart monitoring solution that is recognized by XPRIZE. The solution is to measure pulmonary artery pressure by implanting a tiny biosensor into the patient's body through minimally invasive, low-risk catheterization. Endotronix was founded by Cardiothoracic Surgeon, MD, Anthony I. Nunez, and Dr. Harry D. Rowland, a professional mechanical engineer in micro-nano-scale plastics manufacturing. They developed a wireless sensor that measures pulmonary pressure in the heart. The patient holds an iPad Mini-sized device and places it in the chest for about 15 seconds. The device sends the measured arterial pressure values ​​and information to the patient. The patient's health care physician. Food additives refer to chemical synthetic or natural substances added to food for the purpose of improving the quality, color, aroma and taste of food, as well as for the need of preservative and processing technology. Due to the rapid development of the food industry, food additives have become an important part of the modern food industry, and has become an important driving force of technological progress and technological innovation in the food industry. In the use of food additives, in addition to ensuring their due function and role, the most important thing is to ensure the safety and health of food. Supplement Ingredients,Gamma Aminobutyric Acid,Alpha Gpc Powder,Organic Spirulina Powder Xi'an Double H Health Technology Co., Ltd , https://www.xahnhcj.com
